Kennedy Capital Management’s Cantel Medical Corporation CMD Stock Holding History

Kennedy Capital Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-13,871	Closed	-$983K	–	766
2019 Q4	$983K	Buy	+13,871	New	+$1.01M	0.02%	614
2018 Q3	–	Sell	-70,072	Closed	-$6.89M	–	786
2018 Q2	$6.89M	Sell	70,072 -5,594	-7%	-$626K	0.13%	297
2018 Q1	$8.43M	Sell	75,666 -1,233	-2%	-$138K	0.16%	196
2017 Q4	$7.91M	Buy	76,899 +2,110	+3%	+$210K	0.14%	234
2017 Q3	$7.04M	Sell	74,789 -10,774	-13%	-$850K	0.13%	276
2017 Q2	$6.67M	Buy	+85,563	New	+$6.43M	0.13%	278
2014 Q2	–	Sell	-150,406	Closed	-$5.07M	–	778
2014 Q1	$5.07M	Sell	150,406 -28,943	-16%	-$955K	0.1%	368
2013 Q4	$6.08M	Sell	179,349 -8,267	-4%	-$286K	0.11%	336
2013 Q3	$5.98M	Sell	187,616 -4,492	-2%	-$119K	0.12%	329
2013 Q2	$4.34M	Buy	+192,108	New	+$4.16M	0.09%	390

Other funds holding CMD

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Kennedy Capital Management's CMD Position: Q1 2020 in Review

Kennedy Capital Management sold out of Cantel Medical Corporation (CMD) in Q1 2020, closing a stake of 13,871 shares — an estimated $983K sold.

Kennedy Capital Management first reported a position in CMD in Q2 2013 and held it in 10 quarters. The position peaked at $8.43M in Q1 2018. 213 funds tracked by Wall St. Rank hold CMD as of Q1 2020.

Kennedy Capital Management reported no remaining Cantel Medical Corporation position as of Q1 2020 after selling out during the quarter.
Kennedy Capital Management sold 13,871 Cantel Medical Corporation shares in Q1 2020, an estimated $983K.
Kennedy Capital Management first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 10 quarters.
Kennedy Capital Management's Cantel Medical Corporation position peaked at $8.43M in Q1 2018.
213 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2020.

Based on Kennedy Capital Management's 13F filing for Q1 2020, filed 15 May 2020.